Sign In

Angelica Peebles

Reporter at Bloomberg

Angelica Peebles is a journalist currently working as a Health and Pharmaceutical Reporter at CNBC, based in Englewood Cliffs, New Jersey. She joined CNBC in September 2023, where she covers topics such as biotech, obesity drug development, and mergers and acquisitions in the pharmaceutical industry.134

Before her role at CNBC, Peebles worked at Bloomberg from 2020 to 2023 as a health reporter covering the biotech sector from the Boston bureau. She also previously worked at CNBC from 2017 to 2020 as a consumer health reporter.13

Peebles holds a Bachelor of Science degree in News-Editorial Journalism from the University of Illinois at Urbana-Champaign, where she graduated in 2017.23

Highlights

May 3 · linkedin

The flu shots most of us take today aren't great. They're our best defense against influenza, but they leave much to be desired. Pfizer and Moderna want to use mRNA, the technology behind their Covid-19 shots, to make better flu shots. The three companies that currently dominate the market -- GSK, Sanofi and CSL Seqirus -- are also working on mRNA formulations.

“The pandemic showed that not only did it work in people, but it could have a huge public-health impact,” said GSK's Philip Dormitzer.

More on the prospects (and potential pitfalls) of mRNA from Stéphane Bancel, Annaliesa A., David Morens, Angela Rasmussen, Mike Yee.

Related Questions

What are some of Angelica Peebles' most notable stories at Bloomberg?
How did Angelica Peebles transition from CNBC to Bloomberg?
What specific topics does Angelica Peebles cover in her health reporting?
What inspired Angelica Peebles to pursue a career in health journalism?
How has Angelica Peebles' work impacted the biotech industry?
Angelica Peebles
Angelica Peebles, photo 1
Angelica Peebles, photo 2
Add to my network

Location

Boston, Massachusetts, United States